Revolution Medicines Conference: CEO Details Daraxonrasib Phase III Timeline, First-Line PDAC Push

CEO Mark Goldsmith outlined the company’s late-stage plans for its RAS(ON) inhibitor daraxonrasib, discussed expansion into first-line pancreatic cancer, and offered updates on colorectal cancer and e ...
Nasdaq

Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity

Notes: Safety population, includes all randomized subjects who received at least one dose of study drug. "We are excited to report the top-line results from this important Phase 2 study. VK2735 ...
Nature

Phase Shifters and Transmission Line Technologies

Phase shifters and transmission line technologies are integral components in modern RF and microwave engineering, enabling precise control of signal phase for applications ranging from beamforming in ...
Seeking Alpha

Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment

Luci indicated the company is focused on securing additional funding opportunities to support the Phase 3 ibezapolstat clinical trial program and expects further updates on funding initiatives in ...
Kotaku

Phase Line: Raider Assault

All the Latest Game Footage and Images from Phase Line: Raider Assault Phase Line: Raider Assault allows players to jump into high adrenaline combat arenas in various fictitious environments around ...